Coverage from the

British Society for Rheumatology (BSR) 2021 Annual Meeting

April 26 - 28, 2021; Virtual

April 26 - 28, 2021 Virtual
  • BSR 2021 Rituximab Benefits Seen in Neuropsychiatric Lupus Additionally, the use of concomitant cyclophosphamide might enhance the level of improvement seen in some patients, said Dr Trixy David in presenting data at the British Society for Rheumatology meeting.
  • BSR 2021 RA Biologic's Serious Infection Risk Confounded by Order of Use The risk for serious infection seen with tocilizumab is confounded by whether the drug is given as first-line or as subsequent treatment in the line of therapy.

Conference News

Recent Rheumatology News

  • COVID-19 Vaccination in RMD Patients: Safety Data 'Reassuring' COVID-19 Vaccination in RMD Patients: Safety Data 'Reassuring' Two reports support the safety and immunogenicity of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal diseases (RMDs) and represent the first available data on such patients.
  • VEXAS: A Novel Rheumatologic, Hematologic Syndrome VEXAS: A Novel Rheumatologic, Hematologic Syndrome Older men with a novel adult-onset, severe autoinflammatory syndrome known by the acronym VEXAS are likely hiding in plain sight in many adult rheumatology, hematology, and dermatology practices.
  • Step Therapy: Inside the Fight Against 'Fail First' Medicine Step Therapy: Inside the Fight Against 'Fail First' Medicine Doctors and nurses are leading the movement against insurance requirements that force patients to accept medications other than the ones initially prescribed. Where do laws stand now, and what's next?

Previous Coverage